Publications

  • Rakha E, Pío R, Ilie M, Woolston C, Pajares MJ, Echeveste J, Hughes E, Soomro I, Long E, Iodate MA, Wagner S, Lanchbury J, Baldwin DR, Hofman P, Montuenga LM. Improved Risk Stratification of Resectable, Early Stage Lung Adenocarcinoma Patients Using a Combined Molecular and Pathological Risk Estimator. European Journal of Cancer. En prensa. IF: 5.417; Lugar: 26/211 Oncology. Primer cuartil.
     
  • Sánchez-Salcedo P, Wilson DO, de-Torres JP, Weissfeld JL, Berto J, Campo A, Alcaide AB, Pueyo J, Bastarrika G, Seijo LM, Pajares MJ, Pio R, Montuenga LM, Zulueta JJ. Improving selection criteria for lung cancer screening. The potential role of emphysema. Am J Respir Crit Care Med. 2015; 191: 924-31. IF: 11.986. Lugar: 1/54 Respiratory System. Primer decil. 
    ABSTRACT CORTESÍA DE PUBMED

  • Grbesa I, Pajares MJ, Martínez-Terroba E, Agorreta J, Mikecin AM, Larráyoz M, Idoate MA, Gall-Troselj K, Pio R, Montuenga LM. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients. PLoS One. 2015; 10: e0124670. IF: 3.534. Lugar: 8/55 Multidisciplinary Sciences. Primer cuartil. 
    ABSTRACT CORTESÍA DE PUBMED

  • Pajares MJ, Agorreta J, Salvo E, Behrens C, Wistuba II, Montuenga LM, Pío R, Rouzaut A. TGFBI expression is an independent predictor of survival in adjuvant treated lung squamous cell carcinoma patients. British Journal of Cancer 2014; 110: 1545-1551. IF: 4.817. Lugar: 42/203 Oncology. Primer cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Sandoval J, Méndez-González J, Nadal E, Chen G, Carmona FJ, Sayols S, Morán S, Heyn H, Vizoso M, Gómez A, Sánchez-Céspedes M, Assenov Y, Muller F, Bock C, Tarón M, Mora J, Muscarella LA, Liloglou T, Davies M, Pollan M, et al. A prognostic DNA methylation signature for stage I non-small-cell lung cancer. J Clin Oncol 2013; 31: 4140-4147. IF: 17.960. Lugar: 5/203 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Ajona D, Pajares MJ, Corrales L, Pérez-Gracía JL, Agorreta J, Lozano MD, Torre W, Massion PP, de-Torres JP, Jantus-Lewintre E, Camps C, Zulueta JJ, Montuenga LM, Pío R. Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer. Journal of the National Cancer Insti- tute 2013; 105: 1385-1393. IF: 15.161. Lugar: 8/203 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Bram- billa C, Wistuba, II, Behrens C, Timsit JF, Pío R, Field JK,Montuenga LM. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung. J Clin Oncol 2012; 30: 1129-1136. IF: 18.038; Lugar: 5/197 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Ezponda T, Pajares MJ, Agorreta J, Echeveste JI, López-Picazo JM, Torre W, Pío R, Montuenga LM. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. Clinical Cancer Researcn 2010; 16: 4113-4125. IF: 7.338; Lugar: 16/185 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED



Dr. Luis Montuenga.

More information:

Contact

Contact:
Marisol Ripa
Avda. Pío XII, 55
31008 Pamplona
Spain

(+34) 948 194 700 Ext. 1010
msripa@unav.es